To drive discovery and innovation, leading to the development of targeted and personalised treatments for cancer.
It is no coincidence that Northern Ireland’s cancer survival rates are currently among the best in the UK, despite the increase in cancer incidence here. Since its establishment in 2007, Queen’s Centre for Cancer Research and Cell Biology has gained global recognition for its pioneering research.
That research has translated into dramatic improvements in patient care. Leading international scientists and clinicians are now based in Belfast and key partnerships are in place with Cancer Research UK, the US National Cancer Institute, several universities in the USA and other worldclass organisations. In 2012, Queen’s, in partnership with the local Health and Social Care Trusts, was awarded a Diamond Jubilee Queen’s Anniversary Prize for leading the Northern Ireland Comprehensive Cancer Services Programme, underpinning our reputation as a global centre of excellence for cancer care.
Professor Joe O’Sullivan is leading UK research into radiation oncology to make radiotherapy more targeted, effective and less harmful to healthy tissue. Researchers in the Centre are
also pioneering the development of personalised medicine, enabling doctors to deliver treatments that target the cancer precisely and without harmful side effects. Working in partnership with Almac Diagnostics, Professor Richard Kennedy and his team are developing more effective tests for certain forms of cancer to genetically determine how patients will respond to treatments.
Cancer no longer needs to be seen as an inevitable death sentence. In many instances it can now be viewed instead as a chronic disease.We have achieved so much but we are still at the beginning of a long journey. Why not join us? With your support we can make a real difference to the future of so many people.
“To take part in a clinical trial
for a potential new treatment
for advanced prostate
cancer that will help so many
others in the future is an
Allister Murphy, prostrate cancer patient.